Woman and Man
- | Country :
- Slovakia
- Japan
- Canada
- The 5 others...
- | organs : -
- | Specialty : -
Extract
The study will assess the safety and efficacy of intravenous (10mg/kg) and subcutaneous (300mg) secukinumab in moderate to severe chronic plaque-type psoriasis who are partial responders to secukinumab.
Inclusion criteria
- Plaque-type Psoriasis